Consumer Durables FUJIFILM Holdings Corp. Business Summary
FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Healthcare and Materials Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, and instant photo systems. The Healthcare and Materials Solutions segment covers medical system equipment, cosmetics and supplements, pharmaceuticals, biopharmacy manufacturing and development contracts, regenerative medicine products, chemical products, graphic system equipment, inkjet equipment, display materials, recording media, and electronic materials. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, and paper and consumables. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.
Financial Highlights
Mar 2022
JPY USD Revenue 2,525.77B 22,476.75M Gross Profit 1,033.22B 9,194.61M Operating income 229,702M 2,044.10M Income before tax 260,446M 2,317.69M Net income 211,180M 1,879.28M EBITDA 362,701M 3,227.66M Diluted EPS 526.22 4.68 Dividends Per Share 110 0.97 Total Assets 3,955.28B 32,587.27M Total liabilities 1,430.34B 11,784.47M Total equity 2,502.65B 20,619.21M Operating cash flow 323,934M 2,882.67M Currency in JPY Currency in USD
Historical Data Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
2,433.36B
2,431.48B
2,315.14B
2,192.51B
2,525.77B
Gross Profit
969,096M
997,516M
954,493M
869,691M
1,033.22B
Operating income
161,316M
216,184M
186,570M
165,473M
229,702M
Income before tax
197,807M
212,762M
173,071M
235,870M
260,446M
Net income
140,694M
138,106M
124,987M
181,205M
211,180M
EBITDA
288,958M
346,116M
309,223M
288,896M
362,701M
Diluted EPS
321.54
325.82
305.21
451.74
526.22
Dividends Per Share
75
80
95
100
110
Total Assets
3,492.94B
3,414.69B
3,321.69B
3,549.20B
3,955.28B
Total liabilities
1,194.23B
1,169.85B
1,327.93B
1,327.04B
1,430.34B
Total equity
2,079.13B
2,036.96B
1,953.25B
2,204.56B
2,502.65B
Operating cash flow
261,152M
249,343M
255,667M
420,861M
323,934M
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
21,955.35M
21,926.11M
21,293.39M
20,672.94M
22,476.75M
Gross Profit
8,743.79M
8,995.16M
8,778.90M
8,200.19M
9,194.61M
Operating income
1,455.49M
1,949.45M
1,715.96M
1,560.22M
2,044.10M
Income before tax
1,784.73M
1,918.59M
1,591.81M
2,223.98M
2,317.69M
Net income
1,269.43M
1,245.38M
1,149.56M
1,708.55M
1,879.28M
EBITDA
2,607.16M
3,121.12M
2,844.06M
2,723.95M
3,227.66M
Diluted EPS
2.90
2.93
2.80
4.25
4.68
Dividends Per Share
0.67
0.72
0.87
0.94
0.97
Total Assets
32,843.81M
30,850.54M
30,769.22M
32,119.48M
32,587.27M
Total liabilities
11,229.27M
10,569.19M
12,300.81M
12,009.46M
11,784.47M
Total equity
19,549.91M
18,403.24M
18,093.20M
19,950.82M
20,619.21M
Operating cash flow
2,356.27M
2,248.46M
2,351.48M
3,968.23M
2,882.67M
Valuation Measures
Mar 2022
PER 14.22 ROA 5.62% ROE 8.97% Operating margin 9.09% Profit margin 8.36%
Key executives
President, CEO & Representative Director:
Teiichi Goto
Chief Financial Officer & Director:
Masayuki Higuchi
Director, VP & Chief Technology Officer:
Takashi Iwasaki
Executive Officer & Accounting Manager:
Masaru Yoshizawa
Executive Officer & Manager-Personnel:
Yasushi Zama Shareholders
FUJIFILM Holdings Corp. (22.0%)
Nomura Asset Management Co., Ltd. (4.7%)
Nippon Life Insurance Co. (3.0%)
Daiwa Asset Management Co. Ltd. (2.1%)
Nikko Asset Management Co., Ltd. (2.0%)
The Vanguard Group, Inc. (1.8%)
Sumitomo Mitsui Financial Group, Inc. (1.8%)
Fidelity Management & Research Co. LLC (1.6%)
BlackRock Fund Advisors (1.4%)
Daicel Corp. (1.1%)
Related Companies
FUJIFILM Intellectual Property Research Co. Ltd.
FUJIFILM Photo Manufacturing Co. Ltd.
Fujifilm UNIGRAPHICA AG
Fujifilm Holdings Restricted Stock Compensation Plan
Fujifilm Sonosite France SARL
Fujifilm Microdevices Co., Ltd.
Fujifilm Colombia SAS
DS Chemport (Australia) Pty Ltd.
Fujifilm Co., Ltd.
FX Global Supply Solutions, Inc.
Fuji Xerox Industry Development (China) Co., Ltd.
FUJIFILM Printing Plate (China) Co., Ltd.
FUJIFILM Electronic Materials Korea Co. Ltd.
Fuji Xerox Eco-Manufacturing (Suzhou) Co., Ltd.
FUJIFILM Printing Plate Co., Ltd.
FUJIFILM Hungary Ltd.
FUJIFILM (Shanghai) Trading Co., Ltd.
PT Modern Foto
Fujitsu General Co, Ltd.
FUJIFILM Sericol India Pvt Ltd.
FUJIFILM Italia SpA
FUJIFILM Hong Kong Ltd.
FUJIFILM Holdings France SAS
Fuji Xerox of Shenzhen Ltd.
Fuji Xerox Industry Development (Shanghai) Co., Ltd.
Fuji Xerox Far East Ltd.
FX Global, Inc.
Salmat Asia Ltd.
Fuji Hunt Photographic Chemicals Pte Ltd.
Fuji Graphic Systems Canada, Inc.
Competitors
Canon Inc.
Eastman Kodak Company
Butterfly Network, Inc. Class A
Sindoh Co., Ltd
Vieworks Co., Ltd
Hologic, Inc.
STCUBE, Inc.
Charles River Laboratories International, Inc.
Primax Electronics Ltd.
Lucky Film Co., Ltd. Class A
Careray Digital Medical Technology Co. Ltd. Class A
NANO-X IMAGING LTD
Young Optics Inc.
Celltrion, Inc.
ENDRA Life Sciences Inc.
Pulsenmore Ltd.
Uni-Pixel, Inc.
Hyperfine, Inc. Class A
SAMSUNG BIOLOGICS Co., Ltd.
Iray Technology Co., Ltd Class A
Sectra AB Class B
Emergent BioSolutions Inc.
Binex Co., Ltd
BioCardia, Inc.
BioCryst Pharmaceuticals, Inc.
Check-Cap Ltd.
Cocrystal Pharma Inc
Coherus BioSciences, Inc.
Crystal Clear Electronic Material Co., Ltd. Class A
Gamida Cell Ltd.
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 29 Nov, 2022
Take your reading anywhere with offline reading functions Never miss a story with breaking news alerts Customize your reading experience
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close
